Ethics approval and consent to participate
This study was approved by the Institutional Review Board of the 1st Affiliated Hospital with Nanjing Medical University (IRB #2020-SR-059) on March 11, 2020 and written informed consent was obtained from all subjects participating in the trial. All methods were performed following the relevant guidelines and regulations.